
DNA vs EXEL
$DNA vs $EXEL head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNA vs EXEL: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8%). Split-adjusted daily closes.
- ·Their trends point opposite ways: EXEL is above both its 50- and 200-day averages while DNA is below both.
- ·Only EXEL beat the market over the past year, by 48.2%, while DNA trailed the S&P 500 at +8% by 4.4%.
- ·EXEL has support 12.9% below at $56.90; DNA has no tested support within 35% under its price.
- ·DNA is within 2.6% of resistance at $8.40, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
DNA vs EXEL: the quick read
- ·EXEL is the larger company by market cap ($16.66B vs $568M).
- ·DNA has been more active on our scanner (202 vs 114 alerts in 30 days).
- ·DNA has the smaller float (65.6M vs 226.8M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·DNA trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 202 and 114 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: EXEL is more than 29x the market cap of DNA, so the same dollar of news moves DNA far harder.
- ·They have diverged badly over the year: EXEL is near the top of its 52-week range while DNA is near the bottom of its own.
Objective differences only. Not investment advice.
Watching DNA or EXEL? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNA and EXEL on TheDesperateTrader.
- Is DNA or EXEL the better stock?
- "Better" depends on your goal, and these two are not alike. EXEL is the larger company by market cap ($16.66B vs $568M). DNA has been more active on our scanner (202 vs 114 alerts in 30 days). DNA has the smaller float (65.6M vs 226.8M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNA and EXEL?
- The differences that matter: EXEL is roughly 29x the size of the other by market cap ($568M vs $16.66B); they trade at very different share prices ($8.18 vs $65.32); DNA sits at 22% of its 52-week range against 75% for EXEL; our scanner flagged DNA 202 times in the last 30 days against 114 for EXEL. Everything above is measured from the latest completed session and SEC filings.
- Which of DNA and EXEL is more active right now?
- Right now DNA is at about 0.7x its normal volume and EXEL is at about 0.7x, so DNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is DNA or EXEL in the stronger trend?
- DNA is below its 50-day average of $10.41 and below its 200-day average of $8.63; EXEL is above its 50-day average of $63.03 and above its 200-day average of $52.75. EXEL leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNA or EXEL? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNA and EXEL comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.